Emens LA - Search Results

1

Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.

Ojalvo LS, Thompson ED, Wang TL, Meeker AK, Shih IM, Fader AN, Cimino-Mathews A, Emens LA. Ojalvo LS, et al. Among authors: emens la. Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27. Hum Pathol. 2018. PMID: 29288043

2

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Emens LA. Emens LA. Expert Rev Anticancer Ther. 2012 Dec;12(12):1597-611. doi: 10.1586/era.12.147. Expert Rev Anticancer Ther. 2012. PMID: 23253225 Free PMC article. Review.

3

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.

Cimino-Mathews A, Ye X, Meeker A, Argani P, Emens LA. Cimino-Mathews A, et al. Among authors: emens la. Hum Pathol. 2013 Oct;44(10):2055-63. doi: 10.1016/j.humpath.2013.03.010. Epub 2013 May 21. Hum Pathol. 2013. PMID: 23701942 Free PMC article.

4

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P. Cimino-Mathews A, et al. Among authors: emens la. Hum Pathol. 2013 Nov;44(11):2494-500. doi: 10.1016/j.humpath.2013.06.009. Epub 2013 Jul 31. Hum Pathol. 2013. PMID: 23916291 Free PMC article.

5

Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs.

VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. VandenBussche CJ, et al. Among authors: emens la. Am J Surg Pathol. 2015 Jul;39(7):939-47. doi: 10.1097/PAS.0000000000000424. Am J Surg Pathol. 2015. PMID: 25871620

6

Immune targeting in breast cancer.

Cimino-Mathews A, Foote JB, Emens LA. Cimino-Mathews A, et al. Among authors: emens la. Oncology (Williston Park). 2015 May;29(5):375-85. Oncology (Williston Park). 2015. PMID: 25979549 Free article. Review.

7

Antagonists of PD-1 and PD-L1 in Cancer Treatment.

Lipson EJ, Forde PM, Hammers HJ, Emens LA, Taube JM, Topalian SL. Lipson EJ, et al. Among authors: emens la. Semin Oncol. 2015 Aug;42(4):587-600. doi: 10.1053/j.seminoncol.2015.05.013. Epub 2015 Jun 10. Semin Oncol. 2015. PMID: 26320063 Free PMC article. Review.

8

Emerging immunotherapies in ovarian cancer.

Ojalvo LS, Nichols PE, Jelovac D, Emens LA. Ojalvo LS, et al. Among authors: emens la. Discov Med. 2015 Sep;20(109):97-109. Discov Med. 2015. PMID: 26463091 Free article. Review.

9

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.

Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA. Cimino-Mathews A, et al. Among authors: emens la. Hum Pathol. 2016 Jan;47(1):52-63. doi: 10.1016/j.humpath.2015.09.003. Epub 2015 Sep 21. Hum Pathol. 2016. PMID: 26527522 Free PMC article.

10

The immune microenvironment of breast ductal carcinoma in situ.

Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA. Thompson E, et al. Among authors: emens la. Mod Pathol. 2016 Mar;29(3):249-58. doi: 10.1038/modpathol.2015.158. Epub 2016 Jan 15. Mod Pathol. 2016. PMID: 26769139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters